ASX:PMEHealthcare Services
A Look At Pro Medicus (ASX:PME) Valuation After Half Year Results And Interim Dividend Announcement
Pro Medicus (ASX:PME) is back in focus after releasing half year 2025 results alongside an interim dividend, giving investors fresh numbers on sales, earnings and cash returns via a A$0.32 per share payout.
See our latest analysis for Pro Medicus.
The market reaction has been mixed, with a 7.69% 1 day share price return following the half year earnings and dividend update, set against a 30 day share price return of 37.92% decline and a 1 year total shareholder return of 54.91% decline...